The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review

Maria Rosaria Paravati , Giuseppe Guido Maria Scarlata , Maja Milanović , Nataša Milić , Ludovico Abenavoli

Hepatoma Research ›› 2024, Vol. 10 : 43

PDF
Hepatoma Research ›› 2024, Vol. 10:43 DOI: 10.20517/2394-5079.2024.86
Review

The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review

Author information +
History +
PDF

Abstract

Hepatocellular carcinoma (HCC) ranks as the third leading cause of cancer-related deaths worldwide. It presents a significant and rising global health challenge due to its complex development, high mortality rate, and poor prognosis. The primary treatment methods include chemotherapy, radiotherapy, and surgery, yet each is associated with severe side effects. While combination therapies can enhance outcomes, they also tend to amplify the adverse effects. For this reason, the prevention of HCC has a major impact on world health. Current knowledge indicates that a healthy lifestyle combined with a healthy diet is an excellent preventive strategy. In this respect, the Mediterranean diet represents a valid preventive strategy widely recognized by the scientific community. Its effectiveness is proven by the presence of several polyphenols in its main foods, including quercetin, luteolin, myricetin, and kaempferol. These polyphenols are present in different functional foods and show anticancer activity. This narrative review aims to assess the anti-HCC activity of these polyphenols that characterize the Mediterranean diet.

Keywords

Quercetin / luteolin / myricetin / kaempferol / Mediterranean diet / prevention / therapy

Cite this article

Download citation ▾
Maria Rosaria Paravati, Giuseppe Guido Maria Scarlata, Maja Milanović, Nataša Milić, Ludovico Abenavoli. The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review. Hepatoma Research, 2024, 10: 43 DOI:10.20517/2394-5079.2024.86

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Sayiner M,Younossi ZM.Disease burden of hepatocellular carcinoma: a global perspective.Dig Dis Sci2019;64:910-7

[2]

Reddy KR,Marsh T.Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter hepatocellular carcinoma early detection strategy (HEDS) study.Gastroenterology2023;165:1053-1063.e6 PMCID:PMC10529044

[3]

Desai A,Lai JP.Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review.World J Hepatol2019;11:1-18 PMCID:PMC6354117

[4]

Samant H,Zibari GB.Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management.J Gastrointest Oncol2021;12:S361-73 PMCID:PMC8343080

[5]

Ge XY,Wang TY.Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model.Front Oncol2023;13:1067353 PMCID:PMC10073455

[6]

Scarlata GGM,Spagnuolo R.Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma.Hepatoma Res2024;10:19

[7]

Colaci C,Maria Scarlata GG.Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease.Hepatoma Res2024;10:16

[8]

Marascio N,Romeo I.Real-life 3D therapy failure: analysis of NS5A 93H RAS plus 108 K polymorphism in complex with ombitasvir by molecular modeling.J Med Virol2018;90:1257-63

[9]

Romeo I,Pavia G.Structural modeling of new polymorphism clusters of HCV polymerase isolated from direct - acting antiviral naïve patients: focus on dasabuvir and setrobuvir binding affinity.ChemistrySelect2018;3:6009-17

[10]

Marascio N,Pavia G.Clinical, virological characteristics, and outcomes of treatment with sofosbuvir/ledipasvir in two pediatric patients infected by HCV genotype 4.Cells2019;8:416 PMCID:PMC6562692

[11]

El-Serag HB,Asrani SK.Prevention of hepatocellular carcinoma (HCC). White paper of the texas collaborative center for hepatocellular cancer (TeCH) multi-stakeholder conference.Clin Gastroenterol Hepatol2023;21:2183-92 PMCID:PMC10524305

[12]

Abenavoli L,Paravati MR,Luzza F.Gut microbiota and liver transplantation: immune mechanisms behind the rejection.Biomedicines2023;11:1792 PMCID:PMC10376769

[13]

Key TJ,Willett WC,Spencer EA.Diet, nutrition and the prevention of cancer.Public Health Nutr2004;7:187-200

[14]

Vogtmann E,Li HL.Fruit and vegetable intake and the risk of colorectal cancer: results from the Shanghai men’s health study.Cancer Causes Control2013;24:1935-45 PMCID:PMC3805771

[15]

Turati F,Polesel J.Mediterranean diet and hepatocellular carcinoma.J Hepatol2014;60:606-11

[16]

Montella M,Giudice A.HCC, diet and metabolic factors: diet and HCC.Hepat Mon2011; 11:159-62 PMCID:PMC3206690

[17]

George ES,Broughton A.The association between diet and hepatocellular carcinoma: a systematic review.Nutrients2021;13:172 PMCID:PMC7826815

[18]

Bamia C,Jenab M.Fruit and vegetable consumption in relation to hepatocellular carcinoma in a multi-centre, European cohort study.Br J Cancer2015;112:1273-82 PMCID:PMC4385950

[19]

Zhang W,Li HL.Vegetable-based dietary pattern and liver cancer risk: results from the Shanghai women’s and men’s health studies.Cancer Sci2013;104:1353-61 PMCID:PMC3879410

[20]

Bogumil D,Le Marchand L.High-quality diets are associated with reduced risk of hepatocellular carcinoma and chronic liver disease: the multiethnic cohort.Hepatol Commun2019;3:437-47 PMCID:PMC6396362

[21]

Li WQ,McGlynn KA.Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study.Hepatology2014;60:588-97 PMCID:PMC4110163

[22]

Ma Y,Simon TG.Dietary patterns and risk of hepatocellular carcinoma among U.S. men and women.Hepatology2019;70:577-86 PMCID:PMC6545168

[23]

Keys A,Aravanis C.The seven countries study: 2,289 deaths in 15 years.Prev Med1984;13:141-54

[24]

Farchi G,Mariotti S.Alcohol and mortality in the Italian rural cohorts of the seven countries study.Int J Epidemiol1992;21:74-81

[25]

Farchi G,Giampaoli S,Menotti A.Alcohol and survival in the Italian rural cohorts of the seven countries study.Int J Epidemiol2000;29:667-71

[26]

Schwingshackl L,Hoffmann G.Mediterranean diet and health status: active ingredients and pharmacological mechanisms.Br J Pharmacol2020;177:1241-57 PMCID:PMC7056467

[27]

Abenavoli L,Paravati MR.Mediterranean diet: the beneficial effects of lycopene in non-alcoholic fatty liver disease.J Clin Med2022;11:3477 PMCID:PMC9225137

[28]

Aghababaei F.Recent advances in potential health benefits of quercetin.Pharmaceuticals (Basel)2023;16:1020 PMCID:PMC10384403

[29]

Wang Z,Wang Z,Chen J.Dietary luteolin: a narrative review focusing on its pharmacokinetic properties and effects on glycolipid metabolism.J Agric Food Chem2021;69:1441-54

[30]

Imran M,Hussain G.Myricetin: a comprehensive review on its biological potentials.Food Sci Nutr2021;9:5854-68 PMCID:PMC8498061

[31]

Alam W,Shah MA,Saso L.Kaempferol as a dietary anti-inflammatory agent: current therapeutic standing.Molecules2020;25:4073 PMCID:PMC7570692

[32]

Paravati MR,Milanović M.Onion polyphenols as multi-target-directed ligands in MASLD: a preliminary molecular docking study.Nutrients2024;16:1226 PMCID:PMC11054911

[33]

Procopio AC,Scarlata GGM.Is the mediterranean diet a good preventive measure for NASH?.Hepatoma Res2023;10:9

[34]

Seufi AM,Elmaghraby TK.Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences.J Exp Clin Cancer Res2009;28:80 PMCID:PMC2700810

[35]

Carrasco-Torres G,Martínez-Guerra AA.Quercetin reverses rat liver preneoplastic lesions induced by chemical carcinogenesis.Oxid Med Cell Longev2017;2017:4674918 PMCID:PMC5504959

[36]

Raghunath A,Arfuso F,Perumal E.Dysregulation of Nrf2 in hepatocellular carcinoma: role in cancer progression and chemoresistance.Cancers (Basel)2018;10:481 PMCID:PMC6315366

[37]

Guang LH,Feng LF. Quercitrin suppresses hepatocellular carcinoma. Available from: https://www.oncotarget.com/article/23777/text/. [Last accessed on 10 Oct 2024].

[38]

Wu R,Xiong J.Quercetin, the ingredient of xihuang pills, inhibits hepatocellular carcinoma by regulating autophagy and macrophage polarization.Front Biosci (Landmark Ed)2022;27:323

[39]

Zou H,Ge W,Mou XZ.Synergistic anti-tumour effects of quercetin and oncolytic adenovirus expressing TRAIL in human hepatocellular carcinoma.Sci Rep2018;8:2182 PMCID:PMC5794998

[40]

Ji Y,Ma YX.Quercetin inhibits growth of hepatocellular carcinoma by apoptosis induction in part via autophagy stimulation in mice.J Nutr Biochem2019;69:108-19 PMCID:PMC9659433

[41]

Wu L,Liu T.Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway.Cancer Med2019;8:4806-20 PMCID:PMC6712453

[42]

Marbaniang C, Myrthong E, Priya S, et al. Evaluation of antioxidant properties of quercetin in DEN-induced hepatocellular carcinoma in BALB/c mice. The NEHU J 2019;27:94-106. Available from: https://api.semanticscholar.org/CorpusID:220632067. [Last accessed on 10 Oct 2024].

[43]

Hisaka T,Sato T.Quercetin suppresses proliferation of liver cancer cell lines in vitro.Anticancer Res2020;40:4695-700

[44]

Abdu S,Amin A,Miled N.Effects of sorafenib and quercetin alone or in combination in treating hepatocellular carcinoma: in vitro and in vivo approaches.Molecules2022;27:8082 PMCID:PMC9697794

[45]

Wu R,Zhou T.Quercetin/anti-PD-1 antibody combination therapy regulates the gut microbiota, impacts macrophage immunity and reshapes the hepatocellular carcinoma tumor microenvironment.Front Biosci (Landmark Ed)2023;28:327

[46]

Abenavoli L,Svegliati Baroni G.Perspective on the role of gut microbiome in the treatment of hepatocellular carcinoma with immune checkpoint inhibitors.Medicina (Kaunas)2023;59:1427 PMCID:PMC10456509

[47]

Rafacho BP,Liu C,Ausman LM.Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice.Hepatobiliary Surg Nutr2015;4:124-34 PMCID:PMC4405419

[48]

Yee SB,Chung SW.Growth inhibition of luteolin on HepG2 cells is induced via p53 and Fas/Fas-ligand besides the TGF-β pathway.Int J Oncol2015;47:747-54

[49]

Cao Z,Cai X.Luteolin promotes cell apoptosis by inducing autophagy in hepatocellular carcinoma.Cell Physiol Biochem2017;43:1803-12

[50]

Elgendy A,Abd elhamid O.The potential therapeutic effect of luteolin against Diethyl nitrosamine induced hepatocellular carcinoma in rats.Benha Vet Med J2019;36:264-73

[51]

Lee Y.Regulation of apoptosis and autophagy by luteolin in human hepatocellular cancer Hep3B cells.Biochem Biophys Res Commun2019;517:617-22

[52]

Feng XQ,Wang RX.Luteolin and sorafenib combination kills human hepatocellular carcinoma cells through apoptosis potentiation and JNK activation.Oncol Lett2018;16:648-53 PMCID:PMC6006184

[53]

Nazim UM.Luteolin sensitizes human liver cancer cells to TRAILinduced apoptosis via autophagy and JNKmediated death receptor 5 upregulation.Int J Oncol2019;54:665-72

[54]

Semwal DK,Combrinck S.Myricetin: a dietary molecule with diverse biological activities.Nutrients2016;8:90 PMCID:PMC4772053

[55]

Harnly JM,Beecher GR.Flavonoid content of U.S. fruits, vegetables, and nuts.J Agric Food Chem2006;54:9966-77

[56]

Tong Y,Wang SJ,Cao YL.Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves.Arch Pharm Res2009;32:527-33

[57]

Yuan X,Hua X.Myricetin ameliorates the symptoms of collagen-induced arthritis in mice by inhibiting cathepsin K activity.Immunopharmacol Immunotoxicol2015;37:513-9

[58]

Kandasamy N.Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin-cadmium induced diabetic nephrotoxic rats.Toxicol Appl Pharmacol2014;279:173-85

[59]

Jose J,Haridas KR.Structural characterization of a novel derivative of myricetin from Mimosa pudica as an anti-proliferative agent for the treatment of cancer.Biomed Pharmacother2016;84:1067-77

[60]

Feng J,Wang Y.Myricetin inhibits proliferation and induces apoptosis and cell cycle arrest in gastric cancer cells.Mol Cell Biochem2015;408:163-70

[61]

Zheng AW,Zhao LQ.Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells.Oncol Lett2017;13:4974-8 PMCID:PMC5452908

[62]

Jiao D.Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway.Oncol Rep2016;36:342-8

[63]

Jung SK,Byun S.Myricetin suppresses UVB-induced skin cancer by targeting Fyn.Cancer Res2008;68:6021-9

[64]

Yang C,Bazer FW.Myricetin suppresses invasion and promotes cell death in human placental choriocarcinoma cells through induction of oxidative stress.Cancer Lett2017;399:10-9

[65]

Li M,Yu X.Myricetin suppresses the propagation of hepatocellular carcinoma via down-regulating expression of YAP.Cells2019;8:358 PMCID:PMC6523269

[66]

Yang W,Li M.Myricetin induces autophagy and cell cycle arrest of HCC by inhibiting MARCH1-regulated Stat3 and p38 MAPK signaling pathways.Front Pharmacol2021;12:709526 PMCID:PMC8558373

[67]

Ricciardi M,Malpeli G.Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.Br J Cancer2015;112:1067-75 PMCID:PMC4366889

[68]

Ma H,Ren J.Myricetin inhibits migration and invasion of hepatocellular carcinoma MHCC97H cell line by inhibiting the EMT process.Oncol Lett2019;18:6614-20 PMCID:PMC6865832

[69]

Ji A,Ma D.Myricetin induces apoptosis and protective autophagy through endoplasmic reticulum stress in hepatocellular carcinoma.Evid Based Complement Alternat Med2022;2022:3115312 PMCID:PMC9168098

[70]

Seydi E,Salimi A,Pourahmad J.Myricetin selectively induces apoptosis on cancerous hepatocytes by directly targeting their mitochondria.Basic Clin Pharmacol Toxicol2016;119:249-58

[71]

Holland TM,Wang Y.Dietary flavonols and risk of Alzheimer dementia.Neurology2020;94:e1749-56 PMCID:PMC7282875

[72]

Veeresham C,Asres K.Aldose reductase inhibitors of plant origin.Phytother Res2014;28:317-33

[73]

Khalil MI.The potential role of honey and its polyphenols in preventing heart diseases: a review.Afr J Tradit Complement Altern Med2010;7:315-21 PMCID:PMC3005390

[74]

Chien HW,Chang YY.Kaempferol suppresses cell migration through the activation of the ERK signaling pathways in ARPE-19 cells.Environ Toxicol2019;34:312-8

[75]

Zhuang Z,Huang B.Kaempferol alleviates the interleukin-1β-induced inflammation in rat osteoarthritis chondrocytes via suppression of NF-κB.Med Sci Monit2017;23:3925-31 PMCID:PMC5566200

[76]

Shin D,Choi YJ.Dietary compound kaempferol inhibits airway thickening induced by allergic reaction in a bovine serum albumin-induced model of asthma.Int J Mol Sci2015;16:29980-95 PMCID:PMC4691161

[77]

Lin CW,Chen MK.Kaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells.PLoS One2013;8:e80883 PMCID:PMC3835430

[78]

Li W,Wang T,Zhang J.Kaempferol induces apoptosis in human HCT116 colon cancer cells via the ataxia-telangiectasia mutated-p53 pathway with the involvement of p53 upregulated modulator of apoptosis.Chem Biol Interact2009;177:121-7

[79]

Deepa M,Satheeshkumar PK.Antioxidant rich Morus alba leaf extract induces apoptosis in human colon and breast cancer cells by the downregulation of nitric oxide produced by inducible nitric oxide synthase.Nutr Cancer2013;65:305-10

[80]

Szliszka E,Janoszka B,Kowalczyk-Ziomek G.Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.Int J Oncol2011;38:941-53

[81]

Nandi D,Vedasiromoni JR,Rana P.Anti-leukemic activity of Wattakaka volubilis leaf extract against human myeloid leukemia cell lines.J Ethnopharmacol2012;144:466-73

[82]

Guo H,Zhang L.Kaempferol induces apoptosis in HepG2 cells via activation of the endoplasmic reticulum stress pathway.Mol Med Rep2016;13:2791-800

[83]

Guo H,Zhang X.Kaempferol induces hepatocellular carcinoma cell death via endoplasmic reticulum stress-CHOP-autophagy signaling pathway.Oncotarget2017;8:82207-16 PMCID:PMC5669883

[84]

Yang G,Aikemu B,Zheng M.Kaempferol exhibits a synergistic effect with doxorubicin to inhibit proliferation, migration, and invasion of liver cancer.Oncol Rep2021;45:32 PMCID:PMC7905650

[85]

Ju PC,Chen PN.Kaempferol inhibits the cell migration of human hepatocellular carcinoma cells by suppressing MMP-9 and Akt signaling.Environ Toxicol2021;36:1981-9

[86]

Han B,Yang QL,Wang XJ.Kaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling.Oncotarget2017;8:86227-39 PMCID:PMC5689680

[87]

Wu XZ,Chen D.Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma.J Gastroenterol Hepatol2007;22:1178-82

[88]

Semenza GL.Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.Oncogene2010;29:625-34 PMCID:PMC2969168

[89]

Huang GW,Lu WQ.Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: impact on neovascularization and survival.World J Gastroenterol2005;11:1705-8 PMCID:PMC4305959

[90]

Tanaka H,Hashimoto N.Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis.Cancer Res2006;66:11263-70

[91]

Yao DF,Yao M,Gu WJ et al.Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int8:407-13

[92]

Mylonis I,Tsakalof A.The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions.Biochem Biophys Res Commun2010;398:74-8

[93]

Cassotta M,Giampieri F.Aging, age-related diseases, oxidative stress and plant polyphenols: is this a true relationship?.MNM2024;17:255-9

[94]

Wang Y,Li Y.Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancer.PLoS One2014;9:e103939 PMCID:PMC4126673

[95]

Alwahsh SM,Forbes S,Lewis PJ.Insulin production and resistance in different models of diet-induced obesity and metabolic syndrome.Int J Mol Sci2017;18:285 PMCID:PMC5343821

PDF

83

Accesses

0

Citation

Detail

Sections
Recommended

/